Results 91 to 100 of about 25,243 (199)
What's New? Most patients with ovarian cancer (OC) relapse after first‐line chemotherapy, and prognosis with second‐line treatment depends largely on the platinum‐free interval. However, reliable biomarkers to predict response to second‐line therapy remain lacking.
Muhammad Habiburrahman +7 more
wiley +1 more source
Biomarkers, Master Regulators and Genomic Fabric Remodeling in a Case of Papillary Thyroid Carcinoma
Dumitru A. Iacobaş
openalex +2 more sources
Risk Factors of Postoperative Hypocalcemia after Total Thyroidectomy of Papillary Thyroid Carcinoma Patients [PDF]
Ji Young Seong +12 more
openalex +1 more source
Abstract Objective To evaluate the outcomes and recurrence patterns and define the parameters that can help to predict high‐risk patients among our 20‐year clinical early‐stage IB–IIA cervical cancer patients treated with traditional (non‐nerve sparing) radical surgery.
Osman Aşıcıoğlu +4 more
wiley +1 more source
Invasive papillary carcinoma of male breast
Breast carcinoma is uncommon in males and constitutes less than one per cent of all cancers in men. Invasive papillary carcinoma is a rare morphological type of breast cancer.
Arora Raman +3 more
doaj
Abstract Objective Early detection of ovarian cancer at stage I is important to improve patients‘ prognosis. The goal of this study was to examine if transvaginal ultrasound (TVU) performed at the same time as cervical cancer screening can facilitate early detection of ovarian cancer.
Hiromasa Fujita +5 more
wiley +1 more source
ABSTRACT Introduction Metastatic papillary renal cell carcinoma (PRCC) is associated with a poor prognosis. Many patients with PRCC respond to first‐ and second‐line systemic chemotherapy treatments; however, few respond to late‐sequence treatment.
Naoto Hodotsuka +7 more
wiley +1 more source
TBCancer: A database for exploring characteristics and functions of tissue‐biased genes in cancer
This study defined 10,921 tissue‐biased genes across 54 normal tissues and 41 cancer types. Tumor‐associated tissue‐biased genes exhibit downregulation, mutations, and epigenetic modifications, correlating with poor clinical outcomes. Their inactivation promotes tumorigenesis by enhancing stemness and immune evasion, highlighting their value as ...
Zhuobin Lin +7 more
wiley +1 more source

